Brisbane, Australia

Core Research Group Pty Ltd

Type 2 Diabetes Mellitus

Diabetes Mellitus

Infections

Communicable Diseases

IGA Glomerulonephritis

Kidney Diseases

Povetacicept

INS068

Tirzepatide

LY3298176

Hengrui Medicine

Lilly

RVAC Medicines

Alpine Immune Sciences Inc, A Subsidiary of Vertex

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Core Research Group Pty Ltd | Brisbane, Australia

Site insights

Work at this site?

Active trials

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Trial sponsors